专利详细信息
专利号 | CN103550173A |
专利标题 | Injection pantoprazole sodium composite freeze-dried powder |
专利权人 | |
发明人 | |
申请号 | CN20131481775 |
申请日 | 2013/10/15 |
公开日 | 2014/2/5 |
优先权号 | |
IPC | A61K00919000; |
专利类型 | |
法律状态查询 | 查看法律状态 |
The invention provides a kind of injection Pantoprazole Sodium composite freeze-dried powder relate to medicine and medicine manufacture technology field comprise following weight portion material composition: 7.24~9.08 parts of Pantoprazole Sodiums 4.34~5.45 parts of chitosan nanos 85.25~89.11 parts of waters for injection.Advantage of the present invention is: 1) in 1: 0.6(Pantoprazole Sodium: the compositions that chitosan nano) ratio forms has more powerful inhibitory action to H+-K+ATP enzyme; 2) can reduce Pantoprazole Sodium consumption clinically reduce Pantoprazole Sodium untoward reaction the 20mg Pantoprazole Sodium of chitosan-containing nanoparticle and not the gastric acid secretion inhibiting effect of the 30mg Pantoprazole Sodium of chitosan-containing nanoparticle are equal to; 3) improved medicine water solublity simultaneously also guaranteed that medicine has good stability; 4) drug-carrying nanometer particle can change film operative mechanism increases medicine to biomembranous permeability is conducive to medicine drug effect performance in cell; 5) the alternative mannitol of chitosan nano as the lyophilizing skeleton agent of freeze-dried powder has been eliminated the active function of mannitol to human body.
没有相关的数据
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。